PHE - Corporate - Acute Drug Harms Surveillance and Early Warning System in UK Emergency Departments

Public Health England (PHE) is seeking to commission an external partner with an existing system and / or capability to deliver an opioid and new psychoactive substances (NPS) clinical harms surveillance programme. The programme will:

- rapidly detect any incident involving synthetic opioids in the heroin or cocaine markets; - monitor the emergence of a synthetic opioid market as seen in North America; - identify health harms associated with toxicity from emerging/new NPS, such as synthetic cannabinoids.

Additional information: Proposals should be emailed to jade.palmer@phe.gov.uk and include the following documentation / information:

1. supporting statement setting out and establishing suitability to undertake the project, including evidence of national/international work within the field of laboratory analysis of illicit drugs/clinical toxicology and programme management; 2. project outline with details of methodology including proposed strategy for laboratory analysis (offering the most cost-effective options most likely to ensure signals are picked up), timescales, and risks; 3. budget (including detailed breakdown of spend); 4. project team CVs. Word count (excluding project team CVs and budget) is a max of 4,000 words.